| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 1.4K | 6.5% | 11.0% |
| Total Income | 1.4K | 6.5% | 11.0% |
| Expenditure | 931.15 | 4.7% | 7.7% |
| PBT | 496.15 | 11.1% | 18.6% |
| Net Profit | 392.59 | 12.6% | 13.9% |
| OPM | 34.56% | 1.12pp | 2.01pp |
| NPM | 27.59% | 1.50pp | 0.71pp |
| EPS | 2.69 | 13.0% | 14.5% |
ResMed Announces Results for Quarter Ended December 31, 2025
04 May 2026 · 4 May, 1:36 am
Summary
ResMed Inc. announced the results of its operations for the quarter ended December 31, 2025, in a press release issued on January 29, 2026. The company's board of directors declared a quarterly cash dividend of US $0.60 per share, payable on March 19, 2026, to holders of record on February 12, 2026. Holders of CHESS Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency.
Key Highlights
- 1
The press release describes the results of operations for the quarter ended December 31, 2025.
- 2
A quarterly cash dividend of US $0.60 per share was declared by the board of directors.
- 3
The dividend record date is February 12, 2026, and payable on March 19, 2026.
- 4
Holders of CHESS Depositary Instruments will receive an equivalent amount in Australian currency.
Informational and educational content only. Not investment advice.